Clinical Trials Browser

Cytokine Release Syndrome, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT04245839 2025-11-05

TRANSCEND FL

Phase 2 Active not recruiting

276 enrolled 2 FDA

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT02625480 2025-09-29

ZUMA-4

Phase 1/2 Active not recruiting

95 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT04697940 2025-09-19

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Phase 1/2 Active not recruiting

33 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT04088864 2025-03-30

CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

Phase 1 Active not recruiting

10 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

FT819 in Subjects With B-cell Malignancies

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

TRANSCEND FL

ZUMA-4

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies